Authors
Zitong Zhang, Futao Cui, Lin Li, Rong Tian, Huijun Zhou
Published in
Clinical nuclear medicine. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
An 80-year-old man with poorly differentiated squamous cell carcinoma underwent 18F-FDG PET/CT for initial staging and treatment response assessment following pembrolizumab therapy. Follow-up PET/CT demonstrated a new FDG-avid focus within the T3 vertebral body without a corresponding CT abnormality. Subsequent contrast-enhanced MRI revealed no structural correlate at the site of uptake. A repeat PET/CT performed 3 months later showed complete resolution of the vertebral lesion without additional treatment. The imaging findings favored transient immune-related inflammatory uptake or a pseudoprogression-like phenomenon rather than true osseous metastasis.
PMID:
43002608
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0